In last trading session, Coherus Biosciences Inc (NASDAQ:CHRS) saw 3.22 million shares changing hands with its beta currently measuring 0.80. Company’s recent per share price
Coherus Biosciences Inc (NASDAQ:CHRS) has a beta value of 0.81 and has seen 1.48 million shares traded in the recent trading session. The company, currently
In today’s recent session, 0.87 million shares of the Coherus Biosciences Inc (NASDAQ:CHRS) have been traded, and its beta is 0.82. Most recently the company’s
Coherus Biosciences Inc (NASDAQ:CHRS)’s traded shares stood at 0.86 million during the last session, with the company’s beta value hitting 0.82. At the close of
In the latest trading session, 0.96 million Coherus Biosciences Inc (NASDAQ:CHRS) shares changed hands as the company’s beta touched 0.81. With the company’s most recent
In recent trading session, Coherus Biosciences Inc (NASDAQ:CHRS) saw 0.43 million shares changing hands at last check today with its beta currently measuring 0.82. Company’s
Coherus Biosciences Inc (NASDAQ:CHRS) has a beta value of 0.82 and has seen 1.07 million shares traded in the recent trading session. The company, currently
In the last trading session, 1.92 million shares of the Coherus Biosciences Inc (NASDAQ:CHRS) were traded, and its beta was 0.83. Most recently the company’s
In the last trading session, 1.9 million shares of the Coherus Biosciences Inc (NASDAQ:CHRS) were traded, and its beta was 0.85. Most recently the company’s
Coherus Biosciences Inc (NASDAQ:CHRS)’s traded shares stood at 1.05 million during the last session, with the company’s beta value hitting 0.83. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
